Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiangzhi Xiaopi Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Yueyang Hospital of Integrated Chinese and Western Medicine, which is affiliated with the Shanghai University of Traditional Chinese Medicine. The decoction is specifically formulated to treat metabolism-related fatty liver disease (MAFLD), a condition characterized by hepatic steatosis associated with metabolic dysfunction. In TCM theory, the formula is typically used to resolve phlegm, remove dampness, and promote blood circulation to alleviate liver stagnation. It is currently being evaluated in clinical trials (e.g., ChiCTR2400083810) to assess its impact on liver fat content, metabolic markers, and overall clinical efficacy in patients with MAFLD.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiangzhi Xiaopi Decoction.